Serum Interleukin-6 Expression Level and Its Clinical Significance in Patients with Dermatomyositis

Objective. To analyze serum interleukin-6 (IL-6) expression level and its clinical significance in patients with dermatomyositis. Methods. Blood samples from 23 adult patients with dermatomyositis (DM), 22 with systemic lupus erythematosus (SLE), 22 with rheumatoid arthritis (RA), 16 with Sjögren�...

Full description

Saved in:
Bibliographic Details
Main Authors: Min Yang, Xiaomin Cen, Qibing Xie, Chuan Zuo, Guixiu Shi, Geng Yin
Format: Article
Language:English
Published: Wiley 2013-01-01
Series:Clinical and Developmental Immunology
Online Access:http://dx.doi.org/10.1155/2013/717808
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832568052874477568
author Min Yang
Xiaomin Cen
Qibing Xie
Chuan Zuo
Guixiu Shi
Geng Yin
author_facet Min Yang
Xiaomin Cen
Qibing Xie
Chuan Zuo
Guixiu Shi
Geng Yin
author_sort Min Yang
collection DOAJ
description Objective. To analyze serum interleukin-6 (IL-6) expression level and its clinical significance in patients with dermatomyositis. Methods. Blood samples from 23 adult patients with dermatomyositis (DM), 22 with systemic lupus erythematosus (SLE), 22 with rheumatoid arthritis (RA), 16 with Sjögren's syndrome (SS), and 20 healthy controls were collected. The IL-6 concentration was detected by chemiluminescence immunoassay. Correlations between IL-6 expression levels and clinical features or laboratory findings in patients with DM were investigated. Results. IL-6 expression level of DM patients was significantly higher than that of normal controls, significantly lower than that of RA patients, and slightly lower than that of SLE or SS patients with no significant differences. The incidence of fever was significantly higher in the IL-6 elevated group. Serum ferritin (SF) and C-reactive protein (CRP) were positively correlated with IL-6. Conclusions. IL-6 plays a less important role in DM than in RA. IL-6 monoclonal antibodies may have poor effect in patients with DM.
format Article
id doaj-art-0c6e769b36af481a913208cd253eb648
institution Kabale University
issn 1740-2522
1740-2530
language English
publishDate 2013-01-01
publisher Wiley
record_format Article
series Clinical and Developmental Immunology
spelling doaj-art-0c6e769b36af481a913208cd253eb6482025-02-03T00:59:47ZengWileyClinical and Developmental Immunology1740-25221740-25302013-01-01201310.1155/2013/717808717808Serum Interleukin-6 Expression Level and Its Clinical Significance in Patients with DermatomyositisMin Yang0Xiaomin Cen1Qibing Xie2Chuan Zuo3Guixiu Shi4Geng Yin5Department of Rheumatology and Immunology, West China Hospital of Sichuan University, Chengdu, Sichuan 610041, ChinaDepartment of Rheumatology and Immunology, West China Hospital of Sichuan University, Chengdu, Sichuan 610041, ChinaDepartment of Rheumatology and Immunology, West China Hospital of Sichuan University, Chengdu, Sichuan 610041, ChinaDepartment of Rheumatology and Immunology, West China Hospital of Sichuan University, Chengdu, Sichuan 610041, ChinaDepartment of Rheumatology and Immunology, West China Hospital of Sichuan University, Chengdu, Sichuan 610041, ChinaDepartment of Rheumatology and Immunology, West China Hospital of Sichuan University, Chengdu, Sichuan 610041, ChinaObjective. To analyze serum interleukin-6 (IL-6) expression level and its clinical significance in patients with dermatomyositis. Methods. Blood samples from 23 adult patients with dermatomyositis (DM), 22 with systemic lupus erythematosus (SLE), 22 with rheumatoid arthritis (RA), 16 with Sjögren's syndrome (SS), and 20 healthy controls were collected. The IL-6 concentration was detected by chemiluminescence immunoassay. Correlations between IL-6 expression levels and clinical features or laboratory findings in patients with DM were investigated. Results. IL-6 expression level of DM patients was significantly higher than that of normal controls, significantly lower than that of RA patients, and slightly lower than that of SLE or SS patients with no significant differences. The incidence of fever was significantly higher in the IL-6 elevated group. Serum ferritin (SF) and C-reactive protein (CRP) were positively correlated with IL-6. Conclusions. IL-6 plays a less important role in DM than in RA. IL-6 monoclonal antibodies may have poor effect in patients with DM.http://dx.doi.org/10.1155/2013/717808
spellingShingle Min Yang
Xiaomin Cen
Qibing Xie
Chuan Zuo
Guixiu Shi
Geng Yin
Serum Interleukin-6 Expression Level and Its Clinical Significance in Patients with Dermatomyositis
Clinical and Developmental Immunology
title Serum Interleukin-6 Expression Level and Its Clinical Significance in Patients with Dermatomyositis
title_full Serum Interleukin-6 Expression Level and Its Clinical Significance in Patients with Dermatomyositis
title_fullStr Serum Interleukin-6 Expression Level and Its Clinical Significance in Patients with Dermatomyositis
title_full_unstemmed Serum Interleukin-6 Expression Level and Its Clinical Significance in Patients with Dermatomyositis
title_short Serum Interleukin-6 Expression Level and Its Clinical Significance in Patients with Dermatomyositis
title_sort serum interleukin 6 expression level and its clinical significance in patients with dermatomyositis
url http://dx.doi.org/10.1155/2013/717808
work_keys_str_mv AT minyang seruminterleukin6expressionlevelanditsclinicalsignificanceinpatientswithdermatomyositis
AT xiaomincen seruminterleukin6expressionlevelanditsclinicalsignificanceinpatientswithdermatomyositis
AT qibingxie seruminterleukin6expressionlevelanditsclinicalsignificanceinpatientswithdermatomyositis
AT chuanzuo seruminterleukin6expressionlevelanditsclinicalsignificanceinpatientswithdermatomyositis
AT guixiushi seruminterleukin6expressionlevelanditsclinicalsignificanceinpatientswithdermatomyositis
AT gengyin seruminterleukin6expressionlevelanditsclinicalsignificanceinpatientswithdermatomyositis